Table 5.
Recurrence and persistence 28 ± 3 days after medications.
| Clindamycin Group (n=41) | FuRong Group (n=39) | P value | |
|---|---|---|---|
| Relapse | |||
| AV | 6 | 10 | 0.22 |
| BV | 5 | 9 | 0.20 |
| Persist | |||
| AV | 4 | 1 | 0.18 |
| BV | 5 | 2 | 0.26 |
Recurrence and persistence 28 ± 3 days after medications.
| Clindamycin Group (n=41) | FuRong Group (n=39) | P value | |
|---|---|---|---|
| Relapse | |||
| AV | 6 | 10 | 0.22 |
| BV | 5 | 9 | 0.20 |
| Persist | |||
| AV | 4 | 1 | 0.18 |
| BV | 5 | 2 | 0.26 |